Skip to content

Archer Aviation

US · ACHR #2343 by market cap Listed 1970
4.67 +0.02 +0.43%
Live - 5344 symbols - heartbeat 309s ago · 2026-10-08 07:00
Pre-market 4.59 -1.71%
After-hours 4.66 -0.21%
Overnight 4.62 -1.07%
Market cap
3.60B
P/B
1.90
EPS
-0.99
Reader sentiment Are you bullish or bearish on ACHR?

Anonymous reader poll. Unscientific, not investment advice.

Valuation each multiple against its own 5-year range

P/B ratio 1.89 In line with history 34th percentile
5-year average 2.86 · #22 of 88 in Aerospace & Defense
P/E ratio -4.31 In line with history 37th percentile
5-year average -3.80 · forward -3.64
P/S ratio 518.93 Expensive vs history 89th percentile
5-year average 561.98 · forward 73.56 · #90 of 91 in Aerospace & Defense

Vs. peers Aerospace & Defense

Company Market cap P/E (TTM) P/B Div yield
Archer Aviation (ACHR) 3.60B -4.32 1.90 0.00%
SpaceX (SPCX) 2.21T -248.30 17.36 0.00%
GE Aerospace (GE) 315.02B 36.19 17.86 0.55%
RTX Corp (RTX) 242.95B 31.74 3.66 1.54%
Boeing (BA) 148.84B 67.74 24.43 0.00%
Lockheed Martin (LMT) 115.22B 18.41 13.14 2.73%

Other StockVane-tracked companies in the same industry.

Morningstar

★★★☆☆ Fair value3.55 Economic moatNone UncertaintyExtreme

Trading 24.1% above Morningstar's fair value estimate.

Fair value

Archer Aviation Inc is assigned a 3-star quantitative star rating, illustrating our stance that this share class is a balanced choice, but prudent investors should consider looking elsewhere. The stock currently trades at a 33% premium over our quantitative fair value estimate of $3.55 per share; however, this estimate should be taken with a pinch of salt due to its extreme uncertainty rating.

The company's lack of profitability undermines our estimated fair value. Companies with low profitability are often less resilient in recessions and are likely to generate weaker future cash flows for shareholders. Reflecting the firm's profitability is its sales yield, which sits in the bottom 1% compared with peers globally. This company's inability to generate significant sales growth without meaningful capital investment is a challenge, which contributes to our view that shares are overvalued.

The company's valuation metrics are an additional cause for concern. A company's valuation metrics provide insights into the market's expectations for its future growth and profitability. The firm's enterprise value to revenue ratio, for example, sits in the top 1% compared with global peers. This overstates the long-term cash flow growth potential of the organization. This characteristic further promotes our unfavorable price/fair value ratio.

Economic moat

This company lacks a competitive advantage, receiving a quantitative economic moat rating of none. Additionally, the firm's moderate financial health score suggests it is acceptably positioned against adverse economic circumstances.

By Quantitative Equity Report

Quote time 2026-10-08 07:00:18 · For reference only, not investment advice and not tailored to your situation.